Dabrafenib plus Trametinib: A breakthrough in pediatric low‐grade glioma therapy
Abstract Background and Aims Pediatric‐type low‐grade gliomas (pLGGs) are the most common solid tumors in children, with v‐raf murine sarcoma viral oncogene homolog B (BRAF) mutations playing a significant role in their development. Dabrafenib and trametinib are targeted therapies that are recently...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2024-01-01
|
| Schriftenreihe: | Health Science Reports |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/hsr2.1841 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|